ENBIO Co., Ltd. (KOSDAQ:352940)

ENBIO Revenue

ENBIO had revenue of 10.44B KRW in the quarter ending June 30, 2026, with 22.51% growth. This brings the company's total for the last twelve months to 36.18B, up 7.81% year-over-year. In the year 2025, ENBIO had annual revenue of 33.95B, down -4.77%. That makes ENBIO the 32,101st largest company in the world by revenue and 2,029th in South Korea.

• Revenue (ttm): 36.18B
• Revenue Growth: +7.81%
• P/S Ratio: 0.60
• Revenue / Employee: 452.28M
• Employees: 80
• Market Cap: 21.71B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

• Disinfectant 12.99B 34.1%
• Pesticide 12.62B 33.1%
• Herbicide 6.83B 17.9%
• Sterile Insecticide 4.12B 10.8%
• Merchandised Products 890.37M 2.3%
• Subcontracting 673.79M 1.8%

By Geography

• South Korea 34.52B 96.8%
• Overseas 1.13B 3.2%

Fiscal year ended Dec 31, 2024 See the full ENBIO breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	33.95B	-1.70B	-4.77%
Dec 31, 2024	35.65B	1.63B	4.79%
Dec 31, 2023	34.02B	-215.53M	-0.63%
Dec 31, 2022	34.24B	773.80M	2.31%
Dec 31, 2021	33.47B	-1.10B	-3.17%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error